Patients under 18 years old who were administered intravenous vancomycin in Department of Pediatrics or Department of Pediatric Cardiology in our institute between April 1st 2011 and March 31st 2016.
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who were administered intravenous vancomycin in Department of Pediatrics or Department of Pediatric Cardiology between April 1st 2011 and March 31st 2016. Age under 18 years when vancomycin was initiated. Written informed consent is obtained.
Exclusion criteria
Exclusion criteria: Patients with renal dysfunction. Data unavailability exists. Lack of informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of the patients who achieved more than 400 of AUC/MIC in the present treatment strategy in our institute. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the duration required for body temperature to be normalized between the populations with AUC/MIC above 400 and below 400. With Monte Carlo simulation, we will optimize the treatment strategy of vancomycin so that more than 90% of the patients achieve AUC/MIC more than 400. | — |
Countries
Japan
Contacts
Yokohama City University Department of Pediatrics